Showing results (2301-2310 of 2,365) with videos related to

Sort By:
Pageof 237
Biomarkers in Medicine|August 25, 2012
Reference measurement procedures for Alzheimer's disease cerebrospinal fluid biomarkers: definitions and approaches with focus on amyloid β42Niklas Mattsson, Ingrid Zegers, Ulf Andreasson, et al.
European Journal of Heart Failure|March 16, 2023
European Society of Cardiology quality indicators for the care and outcomes of adults with pulmonary arterial hypertension. Developed in collaboration with the Heart Failure Association of the European Society of CardiologySuleman Aktaa, Chris P Gale, Margarita Brida, et al.
Cell|January 22, 2021
p53 is a central regulator driving neurodegeneration caused by C9orf72 poly(PR)Maya Maor-Nof, Zohar Shipony, Rodrigo Lopez-Gonzalez, et al.
The New England Journal of Medicine|June 7, 2013
A congenital neutrophil defect syndrome associated with mutations in VPS45Thierry Vilboux, Atar Lev, May Christine V Malicdan, et al.
Human Mutation|July 29, 2011
Genotype and cardiovascular phenotype correlations with TBX1 in 1,022 velo-cardio-facial/DiGeorge/22q11.2 deletion syndrome patientsTingwei Guo, Donna McDonald-McGinn, Anna Blonska, et al.
Transplantation Direct|March 11, 2024
Single-center Outcomes After Liver Transplantation With SARS-CoV-2-Positive Donors: An Argument for Increased UtilizationAshton A Connor, Max W Adelman, Constance M Mobley, et al.
Haematologica|September 18, 2012
The relationship between the severity of hemolysis, clinical manifestations and risk of death in 415 patients with sickle cell anemia in the US and EuropeMehdi Nouraie, Janet S Lee, Yingze Zhang, et al.
Nature Methods|May 29, 2024
A bistable inhibitory optoGPCR for multiplexed optogenetic control of neural circuitsJonas Wietek, Adrianna Nozownik, Mauro Pulin, et al.
Human Genetics|January 9, 2016
Rare copy number variants and congenital heart defects in the 22q11.2 deletion syndromeElisabeth E Mlynarski, Michael Xie, Deanne Taylor, et al.
Bioorganic & Medicinal Chemistry Letters|July 22, 2015
Methyl-substitution of an iminohydantoin spiropiperidine β-secretase (BACE-1) inhibitor has a profound effect on its potencyMelissa Egbertson, Georgia B McGaughey, Steven M Pitzenberger, et al.
Pageof 237